The Find It Early Act requires most health insurance plans, Medicare, Medicaid, TRICARE, and VA benefits to cover certain breast cancer screenings without cost-sharing for specific at-risk groups. It affects individuals at increased breast cancer risk (as determined by medical guidelines), those with dense breast tissue (as defined by the American College of Radiology), and others requiring screening due to factors like age, race, ethnicity, or family history. The bill mandates coverage for various screening methods including mammograms, ultrasounds, MRI, and other technologies at frequencies recommended by the National Comprehensive Cancer Network. This requirement takes effect for plan years beginning January 1, 2026, removing financial barriers to early detection.
The PBM Price Transparency and Accountability Act requires pharmacy benefit managers (PBMs) to be more transparent about drug pricing and ensure accurate payments to pharmacies. It establishes national average drug acquisition cost benchmarks for Medicaid, prohibits PBMs from keeping excessive profits through "spread pricing," and mandates detailed reporting of drug pricing, rebates, and fees. The bill affects Medicaid programs, Medicare Part D plans, and the PBMs that negotiate drug prices on behalf of insurers. It includes enforcement mechanisms like civil penalties for non-compliance and requires PBMs to report detailed pricing information to the Secretary of Health and Human Services.
S 3267, the ASAP Act, would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. The bill defines these tests as FDA-cleared or approved blood, genomic, or imaging-based screenings for pre-symptomatic or early-stage detection. It directly affects Medicare beneficiaries aged 65+ who may be at risk for Alzheimer's, ensuring coverage for these specific tests once approved. The key provision adds these screenings to Medicare's payment system under Section 1833(h)(1)(A) of the Social Security Act.
The Stand Strong Falls Prevention Act establishes an Advisory Committee on Falls Prevention within the Older Americans Act to coordinate federal efforts targeting falls among older adults. The committee will develop a national falls prevention plan, assess current federal programs (including Medicare and Medicaid initiatives), and recommend evidence-based interventions like home modifications and screening tools. It requires annual reports to Congress evaluating program effectiveness, progress on reducing falls-related injuries, and recommendations for expanding successful pilots. The bill directly affects federal agencies, Medicare beneficiaries, and older adults at risk of falls, focusing on concrete policy coordination rather than new funding or mandates.
This bill removes waiting periods for disability and Medicare benefits for people diagnosed with metastatic breast cancer. Specifically, it amends the Social Security Act to add "metastatic breast cancer" to the list of conditions that immediately qualify individuals for disability insurance benefits (eliminating a standard 24-month waiting period) and for Medicare coverage (removing a 24-month waiting period for Medicare Part A). The changes apply only to new applications or benefit periods starting after the bill becomes law. It directly affects patients with metastatic breast cancer seeking timely access to income support and healthcare coverage.
HR 639, the "Doctor Knows Best Act of 2025," prohibits health insurers and federal health programs (like Medicare) from requiring prior authorization, step therapy, or medical necessity reviews for covered medical services. This directly affects patients (who would face fewer delays in care), doctors (who gain more autonomy in treatment decisions), and insurers/federal programs (which must eliminate these review processes). The bill bans these requirements for all covered items/services under private health plans starting January 1, 2026, and for federal programs beginning the same date. It does not change coverage eligibility but removes administrative barriers to accessing approved treatments.
S 3064, the Relief of Chronic Pain Act of 2025, modifies Medicare Part D coverage to improve access to non-opioid treatments for specific chronic pain conditions. It requires Medicare plans to exempt qualifying non-opioid drugs (approved for conditions like diabetic neuropathy, fibromyalgia, or musculoskeletal pain) from deductibles and place them on the lowest cost-sharing tier starting in 2026. The bill also bans step therapy (requiring opioid use first) and prior authorization for these drugs. This directly affects Medicare beneficiaries with the listed chronic pain conditions who rely on these approved non-opioid medications.
The MAP for Care Act establishes a Medicare program enabling beneficiaries (Medicare Part A or Part B enrollees) to register certified advance directives - such as living wills or durable powers of attorney for health care - through accredited online vendors. It requires vendors to meet security standards for storing and sharing directives, ensuring near real-time access for beneficiaries, their designated health care proxies, and providers during medical emergencies. The program includes a state-by-state index of advance directive forms on Medicare’s website, educational resources, and annual surveys to assess accessibility and usability, while respecting existing state laws governing advance directives. Beneficiaries may voluntarily enroll, update, or terminate their directives at any time without cost.
This bill expands Medicare coverage for mental health services provided to seniors in skilled nursing facilities. It removes a current exclusion, allowing clinical social workers to provide covered mental health services under Medicare Part A. Specifically, it adds coverage for a defined set of mental health and behavioral assessment services (using standard codes) that were previously excluded. The changes will take effect for services provided on or after January 1, 2026, directly benefiting seniors residing in skilled nursing facilities seeking these mental health services.
This bill expands Medicare coverage to include certain pharmacist services in medically underserved areas. It allows pharmacists licensed in their state to provide services that would otherwise be covered if done by a physician (like medication management), specifically in health professional shortage areas or medically underserved regions. Medicare would pay 80% of the physician fee schedule rate for these services, starting January 1, 2027. The bill requires the development of new billing codes for pharmacists under Medicare's physician fee schedule. It directly affects pharmacists working in designated underserved communities and Medicare beneficiaries there.